Cases of Myocarditis in the Military Jumped After Biden Vaccine Mandate

Milovan Zrnic / shutterstock.com
Milovan Zrnic / shutterstock.com

A military whistleblower has downloaded the 2021 data from the Defense Medical Epidemiology Database (DMED) and brought it to Sen. Ron Johnson (R-WI). The data showed that the number of myocarditis cases across all branches of the military spiked, starting right after Joe Biden’s illegal mandate to force the COVID shots on everyone went into effect. Myocarditis is a life-threatening inflammation of the heart muscle that causes permanent damage and can lead to death.

All four of the different types of COVID shots in the US now have myocarditis warning labels on them. The Johnson & Johnson vax just had the warning added in March 2023.

Myocarditis cases in the military jumped by 130% in 2021, compared to the previous five-year average. Other serious side effects of the COVID shots showed increases after the mandates went into effect as well. This includes a 41% increase in pulmonary embolisms, a 38% increase in ovarian dysfunction, a 16% increase in testicular cancer, and a 38% increase in complications related to heart disease.

Sen. Johnson is one of the only Members of Congress who has acknowledged that the COVID vaccines are seriously injuring people. He’s also held public meetings with people who have suffered serious vaccine injuries.

Johnson says the military database findings are “disturbing.” Joe Biden forced the troops to get the COVID shots, so every single one of the injuries and deaths that has resulted from that mandate is clearly his fault.

The evidence continues to pile up that the mRNA technology used in these shots – which are not vaccines according to any definition used in epidemiology previously – is dangerous. The risks posed by the shots outweigh any potential reward, especially in young, healthy, and fit people like the ones in the military. Yet the federal government, which is bought and paid for by Big Pharma, still refuses to take the shots off the market.